| Literature DB >> 31811865 |
Maria Jesús Pinazo1, Ana Pereiro2, Rafael Herazo3, Marina Chopita4, Colin Forsyth5, Mabel Lenardón4, Irene Losada6, Faustino Torrico7, Andrea Marchiol5, Mauricio Vera8.
Abstract
Chagas disease (CD) affects over six million people and is a leading cause of heart failure in the Americas. Few are able to access diagnosis and treatment for CD, resulting in a missed opportunity to prevent morbimortality. Integration of testing and treatment with the primary healthcare level is a key step in ensuring affected people receive timely antitrypansomal therapy, which increasing evidence shows can prevent chronic complications from the disease and halt congenital transmission. This article describes three collaborative projects focused on increasing access to testing and treatment for CD through primary healthcare facilities in Bolivia, Argentina, and Colombia.Entities:
Keywords: Access to medicine; Chagas disease; Neglected tropical diseases; Trypanosoma cruzi
Year: 2019 PMID: 31811865 DOI: 10.1016/j.actatropica.2019.105290
Source DB: PubMed Journal: Acta Trop ISSN: 0001-706X Impact factor: 3.112